Oxidative Medicine and Cellular Longevity,
Journal Year:
2021,
Volume and Issue:
2021(1)
Published: Jan. 1, 2021
Oxygen‐free
radicals,
reactive
oxygen
species
(ROS)
or
nitrogen
(RNS),
are
known
by
their
“double‐sided”
nature
in
biological
systems.
The
beneficial
effects
of
ROS
involve
physiological
roles
as
weapons
the
arsenal
immune
system
(destroying
bacteria
within
phagocytic
cells)
and
role
programmed
cell
death
(apoptosis).
On
other
hand,
redox
imbalance
favor
prooxidants
results
an
overproduction
ROS/RNS
leading
to
oxidative
stress.
This
can,
therefore,
be
related
oncogenic
stimulation.
High
levels
disrupt
cellular
processes
nonspecifically
attacking
proteins,
lipids,
DNA.
It
appears
that
DNA
damage
is
key
player
cancer
initiation
formation
8‐OH‐G,
a
potential
biomarker
for
carcinogenesis.
harmful
effect
neutralized
antioxidant
protection
treatment
they
convert
into
less
species.
However,
contradictory
epidemiological
show
supplementation
above
doses
recommended
antioxidants
taken
over
long
period
can
lead
even
increase
risk
cancer.
Thus,
we
describing
here
some
latest
updates
on
involvement
stress
pathology
double
view
this
context
how
could
relevant
management
Journal of Hematology & Oncology,
Journal Year:
2022,
Volume and Issue:
15(1)
Published: June 28, 2022
Abstract
Cancer
is
one
of
the
leading
causes
death
worldwide,
and
factors
responsible
for
its
progression
need
to
be
elucidated.
Exosomes
are
structures
with
an
average
size
100
nm
that
can
transport
proteins,
lipids,
nucleic
acids.
This
review
focuses
on
role
exosomes
in
cancer
therapy.
We
discuss
how
able
modulate
components
tumor
microenvironment
influence
proliferation
migration
rates
cells.
also
highlight
that,
depending
their
cargo,
suppress
or
promote
cell
enhance
reduce
response
radio-
chemo-therapies.
In
addition,
we
describe
trigger
chronic
inflammation
lead
immune
evasion
by
focusing
ability
transfer
non-coding
RNAs
between
cells
other
molecular
signaling
pathways
such
as
PTEN
PI3K/Akt
cancer.
Subsequently,
use
carriers
anti-tumor
agents
genetic
tools
control
progression.
then
tumor-derived
carcinogenesis.
Finally,
devote
a
section
study
diagnostic
prognostic
clinical
courses
important
treatment
patients.
provides
comprehensive
understanding
therapy,
therapeutic
value
remodeling
microenvironment.
Graphical
BMC Cancer,
Journal Year:
2020,
Volume and Issue:
20(1)
Published: Aug. 24, 2020
Abstract
Background
Curcumin
is
herbal
compound
that
has
been
shown
to
have
anti-cancer
effects
in
pre-clinical
and
clinical
studies.
The
of
curcumin
include
inhibiting
the
carcinogenesis,
angiogenesis,
tumour
growth.
This
study
aims
determine
Clinical
different
types
cancers
using
systematic
review
approach.
Methods
A
methodology
adopted
for
undertaking
detailed
analysis
cancer
therapy.
results
presented
this
paper
an
outcome
extracting
findings
studies
selected
from
articles
published
international
databases
including
SID,
MagIran,
IranMedex,
IranDoc,
Google
Scholar,
ScienceDirect,
Scopus,
PubMed
Web
Science
(ISI).
These
were
thoroughly
searched,
relevant
publications
based
on
plausible
keywords,
accordance
with
aims,
as
follows:
prevalence,
curcumin,
features,
cancer.
Results
are
derived
several
consumption
chemotherapy
drugs,
highlighting
increases
effectiveness
radiotherapy
which
improving
patient’s
survival
time,
increasing
expression
anti-metastatic
proteins
along
reducing
their
side
effects.
Conclusion
comprehensive
confirms
reduces
or
radiotherapy,
resulting
patients’
quality
life.
number
reported
that,
increased
patient
time
decreased
tumor
markers’
level.
Molecules,
Journal Year:
2022,
Volume and Issue:
27(23), P. 8367 - 8367
Published: Nov. 30, 2022
Natural
products
have
been
an
invaluable
and
useful
source
of
anticancer
agents
over
the
years.
Several
compounds
synthesized
from
natural
by
modifying
their
structures
or
using
naturally
occurring
as
building
blocks
in
synthesis
these
for
various
purposes
different
fields,
such
biology,
medicine,
engineering.
Multiple
modern
costly
treatments
applied
to
combat
cancer
limit
its
lethality,
but
results
are
not
significantly
refreshing.
products,
which
a
significant
new
therapeutic
drugs,
currently
being
investigated
potential
cytotoxic
shown
positive
trend
preclinical
research
prompted
numerous
innovative
strategies
order
expedite
clinical
research.
becoming
increasingly
important
drug
discovery
due
high
molecular
diversity
novel
biofunctionality.
Furthermore,
can
provide
superior
efficacy
safety
unique
properties.
The
objective
current
review
is
overview
emergence
treatment
prevention
cancer,
chemosensitizers,
immunotherapeutics,
combinatorial
therapies
with
other
formulations
mechanisms
underlying
Cancers,
Journal Year:
2020,
Volume and Issue:
12(8), P. 2276 - 2276
Published: Aug. 14, 2020
Multiple
dysregulated
signaling
pathways
are
implicated
in
the
pathogenesis
of
cancer.
The
conventional
therapies
used
cancer
prevention/treatment
suffer
from
low
efficacy,
considerable
toxicity,
and
high
cost.
Hence,
discovery
development
novel
multi-targeted
agents
to
attenuate
is
great
importance.
In
recent
decades,
phytochemicals
dietary
medicinal
plants
have
been
successfully
introduced
as
alternative
anticancer
due
their
ability
modulate
numerous
oncogenic
oncosuppressive
pathways.
Rutin
(also
known
rutoside,
quercetin-3-O-rutinoside
sophorin)
an
active
plant-derived
flavonoid
that
widely
distributed
various
vegetables,
fruits,
plants,
including
asparagus,
buckwheat,
apricots,
apples,
cherries,
grapes,
grapefruit,
plums,
oranges,
tea.
has
shown
target
inflammatory,
apoptotic,
autophagic,
angiogenic
mediators,
nuclear
factor-κB,
tumor
necrosis
factor-α,
interleukins,
light
chain
3/Beclin,
B
cell
lymphoma
2
(Bcl-2),
Bcl-2
associated
X
protein,
caspases,
vascular
endothelial
growth
factor.
A
comprehensive
critical
analysis
potential
rutin
molecular
targets
amongst
types
not
performed
previously.
Accordingly,
purpose
this
review
present
up-to-date
evaluation
multiple
cellular
mechanisms
through
which
effects
be
exerted.
current
challenges
limitations
well
future
directions
research
also
discussed.
Journal of Cellular Physiology,
Journal Year:
2022,
Volume and Issue:
237(7), P. 2770 - 2795
Published: May 13, 2022
Metastasis
of
tumor
cells
is
a
complex
challenge
and
significantly
diminishes
the
overall
survival
prognosis
cancer
patients.
The
epithelial-to-mesenchymal
transition
(EMT)
well-known
mechanism
responsible
for
invasiveness
cells.
A
number
molecular
pathways
can
regulate
EMT
in
nuclear
factor-kappaB
(NF-κB)
one
them.
translocation
NF-κB
p65
induce
transcription
several
genes
involved
induction.
present
review
describes
interaction
their
association
progression.
Due
to
oncogenic
role
signaling,
its
activation
enhances
metastasis
via
This
has
been
confirmed
various
cancers
including
brain,
breast,
lung
gastric
cancers,
among
others.
ZEB1/2,
transforming
growth
factor-β,
Slug
as
inducers
undergo
upregulation
by
promote
After
induction
driven
NF-κB,
significant
decrease
occurs
E-cadherin
levels,
while
N-cadherin
vimentin
levels
an
increase.
noncoding
RNAs
potentially
also
function
upstream
mediators
modulate
NF-κB/EMT
axis
cancers.
Moreover,
mediating
drug
resistance
Thus,
suppressing
sensitivity
chemotherapeutic
agents.
Carbohydrate Polymers,
Journal Year:
2021,
Volume and Issue:
272, P. 118491 - 118491
Published: July 27, 2021
An
important
motivation
for
the
use
of
nanomaterials
and
nanoarchitectures
in
cancer
therapy
emanates
from
widespread
emergence
drug
resistance.
Although
doxorubicin
(DOX)
induces
cell
cycle
arrest
DNA
damage
by
suppressing
topoisomerase
activity,
resistance
to
DOX
has
severely
restricted
its
anti-cancer
potential.
Hyaluronic
acid
(HA)
been
extensively
utilized
synthesizing
nanoparticles
as
it
interacts
with
CD44
expressed
on
surface
cells.
Cancer
cells
can
take
up
HA-modified
through
receptor-mediated
endocytosis.
Various
types
nanostructures
such
carbon
nanomaterials,
lipid
polymeric
nanocarriers
have
modified
HA
enhance
delivery
acid-based
advanced
materials
provide
a
platform
co-delivery
genes
drugs
along
efficacy
overcome
chemoresistance.
In
present
review,
potential
methods
application
are
discussed.
Journal of Hematology & Oncology,
Journal Year:
2022,
Volume and Issue:
15(1)
Published: March 2, 2022
Non-coding
RNAs
(ncRNAs)
are
a
large
family
of
RNA
molecules
with
no
capability
in
encoding
proteins.
However,
they
participate
developmental
and
biological
processes
their
abnormal
expression
affects
cancer
progression.
These
can
function
as
upstream
mediators
different
signaling
pathways
enhancer
zeste
homolog
2
(EZH2)
is
among
them.
Briefly,
EZH2
belongs
to
PRCs
exert
functional
roles
cells
due
its
methyltransferase
activity.
gene
via
inducing
H3K27me3.
In
the
present
review,
our
aim
provide
mechanistic
discussion
ncRNAs
role
regulating
cancers.
MiRNAs
dually
induce/inhibit
affect
downstream
targets
such
Wnt,
STAT3
EMT.
Furthermore,
miRNAs
regulate
therapy
response
affecting
signaling.
It
noteworthy
that
reduce
miRNA
by
binding
promoter
exerting
Small-interfering
(siRNA)
short-hairpin
(shRNA)
synthetic,
short
capable
reducing
suppressing
LncRNAs
mainly
targeting
miRNAs.
lncRNAs
induce
modulating
expression.
Circular
(CircRNAs),
like
lncRNAs,
areas
discussed
review
focus
on
molecular
leading
clinical
translation.